SCHEMBL3512988

SCHEMBL3512988

S=C=NCc1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2241797 0.80 ADRA2A (0.53)
SCHEMBL2886695 0.79
SCHEMBL13667796 0.78
SCHEMBL8091766 0.77 MIF (0.53)
SCHEMBL3159038 0.77 ADRA2A (0.61)
SCHEMBL23465162 0.76 ADRA2A (0.47)
SCHEMBL8091254 0.76 MIF (0.54)
SCHEMBL8100915 0.74 NAAA (0.56)
SCHEMBL8107617 0.74 NAAA (0.56)
SCHEMBL8104916 0.74 NAAA (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4701635-A1 1,2,4-TRIAZOLE-3-THIONE INHIBITORS OF TREX2 FOR USE IN THE TREATMENT OF PSORIASIS, ATOPIC DERMATITIS OR ICHTHYOSIS Universitat De Barcelona (ES) 2026-03-04 EP disclosed
WO-2024223907-A1 1,2,4-TRIAZOLE-3-THIONE INHIBITORS OF TREX2 FOR USE IN THE TREATMENT OF PSORIASIS, ATOPIC DERMATITIS OR ICHTHYOSIS UNIVERSITAT DE BARCELONA (ES) 2024-10-31 WO disclosed
WO-2023210570-A1 PLANT STOMATAL OPENING REGULATOR 国立大学法人東海国立大学機構 2023-11-02 WO disclosed
CN-112533963-B (meth) acrylate, monomer composition for dental material, molded article, composition for dental material, and method for producing (meth) acrylate 三井化学株式会社 2023-07-25 CN disclosed
US-20230100838-A1 COVALENT RAS INHIBITORS AND USES THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-03-30 US disclosed
US-11552334-B1 Nitrogen-containing compounds as additives for silicon-based Li-ion batteries ENEVATE CORPORATION (US) 2023-01-10 US disclosed
EP-4065231-A1 COVALENT RAS INHIBITORS AND USES THEREOF Revolution Medicines, Inc. (US) 2022-10-05 EP disclosed
CN-114980976-A Covalent RAS inhibitors and uses thereof 锐新医药公司 2022-08-30 CN disclosed
WO-2021108683-A1 COVALENT RAS INHIBITORS AND USES THEREOF Revolution Medicines, Inc. (US) 2021-06-03 WO disclosed
CN-104160324-B Plastic polarized lens and preparation method thereof MITSUI CHEMICALS, INC. (JP) 2016-05-11 CN disclosed
US-5641776-A TREATING RHEUMATOID DISEASES CIBA-GEIGY CORPORATION (US) 1997-06-24 US disclosed
EP-0680473-A1 NOVEL SUBSTITUTED THIOSEMICARBAZONE DERIVATIVES Novartis AG (CH) 1995-11-08 EP disclosed
WO-1995014685-A1 NOVEL SUBSTITUTED THIOSEMICARBAZONE DERIVATIVES CIBA-GEIGY AG (CH) 1995-06-01 WO disclosed
EP-0470006-B1 Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same TERUMO CORP (JP) 1994-12-14 EP disclosed
US-5344842-A Rheumatic diseases CIBA-GEIGY CORPORATION (US) 1994-09-06 US disclosed
EP-0573392-A1 Thiosemicarbazones derivatives and their use as pharmaceuticals CIBA-GEIGY AG (CH) 1993-12-08 EP disclosed
US-5190961-A Bactericides TERUMO KABUSHIKI KAISHA (JP) 1993-03-02 US disclosed
EP-0470006-A1 Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same TERUMO KABUSHIKI KAISHA (JP) 1992-02-05 EP disclosed
EP-0328954-A1 5-Cyano-2,4-diamino-thiazole derivatives BAYER AG (DE) 1989-08-23 EP disclosed
US-4169899-A PENICILLAMINE COMPOUNDS YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1979-10-02 US disclosed